Surgery

1-6 of 6

• 

  MinuteCE®

  Perioperative Immunotherapy in LA-HNSCC: From Evidence to Clinical Practice

  Christophe Le Tourneau, MD, PhD; Marc Oliva, MD, PhD

  0.50 credits 4 episodes

  • 

    

    Christophe Le Tourneau, MD, PhD

  • 

    

    Marc Oliva, MD, PhD

  0.50 credits 4 episodes

• 

  RestartResume

  The Case for Change: Why Perioperative Immunotherapy Matters in LA HNSCC

  RestartResume

  The Case for Change: Why Perioperative Immunotherapy Matters in LA HNSCC

  MinuteCE®

  The Case for Change: Why Perioperative Immunotherapy Matters in LA HNSCC

  Christophe Le Tourneau, MD, PhD; Marc Oliva, MD, PhD

  0.50 program credits

  • 

    

    Christophe Le Tourneau, MD, PhD

  • 

    

    Marc Oliva, MD, PhD

  0.50 program credits

• 

  RestartResume

  The Evidence Base: Key Trials and Emerging Data

  RestartResume

  The Evidence Base: Key Trials and Emerging Data

  MinuteCE®

  The Evidence Base: Key Trials and Emerging Data

  Christophe Le Tourneau, MD, PhD; Marc Oliva, MD, PhD

  0.50 program credits

  • 

    

    Christophe Le Tourneau, MD, PhD

  • 

    

    Marc Oliva, MD, PhD

  0.50 program credits

• 

  RestartResume

  From Data to Decision: Patient Selection and Real-World Application

  RestartResume

  From Data to Decision: Patient Selection and Real-World Application

  MinuteCE®

  From Data to Decision: Patient Selection and Real-World Application

  Christophe Le Tourneau, MD, PhD; Marc Oliva, MD, PhD

  0.50 program credits

  • 

    

    Christophe Le Tourneau, MD, PhD

  • 

    

    Marc Oliva, MD, PhD

  0.50 program credits

• 

  RestartResume

  Building the Team: Integrating Immunotherapy Into Multidisciplinary Care

  RestartResume

  Building the Team: Integrating Immunotherapy Into Multidisciplinary Care

  MinuteCE®

  Building the Team: Integrating Immunotherapy Into Multidisciplinary Care

  Christophe Le Tourneau, MD, PhD; Marc Oliva, MD, PhD

  0.50 program credits

  • 

    

    Christophe Le Tourneau, MD, PhD

  • 

    

    Marc Oliva, MD, PhD

  0.50 program credits

• 

  RestartResume

  Tenosynovial Giant Cell Tumor (TGCT): New Perspectives on Advances in Treatment

  RestartResume

  Tenosynovial Giant Cell Tumor (TGCT): New Perspectives on Advances in Treatment

  CME/CE

  Tenosynovial Giant Cell Tumor (TGCT): New Perspectives on Advances in Treatment

  William D. Tap, MD; Silvia Stacchiotti, MD

  0.25 credits

  • 

    

    William D. Tap, MD

  • 

    

    Silvia Stacchiotti, MD

  • 

    

    Michiel van de Sande, MD, PhD

  • 

    

    Andrew J. Wagner, MD, PhD

  0.25 credits